vs
Cellectis S.A.(CLLS)与TRANSACT TECHNOLOGIES INC(TACT)财务数据对比。点击上方公司名可切换其他公司
TRANSACT TECHNOLOGIES INC的季度营收约是Cellectis S.A.的1.2倍($11.5M vs $9.5M),Cellectis S.A.同比增速更快(375.0% vs 11.9%),Cellectis S.A.自由现金流更多($27.6M vs $589.0K)
Cellectis S.A.是一家法国生物制药公司,专注于开发用于癌症免疫治疗的基因编辑嵌合抗原受体T细胞技术,目前在巴黎、纽约以及北卡罗来纳州罗利均设有办公机构,在肿瘤免疫基因编辑疗法领域拥有多年研发积累。
该公司相关归属主体罗珀技术公司是一家控股集团,主要投资控股科技领域的各类企业,业务覆盖多个科技细分赛道,依托旗下子公司开展多元化科技业务布局。
CLLS vs TACT — 直观对比
营收规模更大
TACT
是对方的1.2倍
$9.5M
营收增速更快
CLLS
高出363.0%
11.9%
自由现金流更多
CLLS
多$27.0M
$589.0K
损益表 — Q2 FY2024 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $9.5M | $11.5M |
| 净利润 | $-25.3M | — |
| 毛利率 | — | 47.6% |
| 营业利润率 | -181.1% | -10.1% |
| 净利率 | -265.9% | — |
| 营收同比 | 375.0% | 11.9% |
| 净利润同比 | -51.9% | — |
| 每股收益(稀释后) | $-0.28 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CLLS
TACT
| Q4 25 | — | $11.5M | ||
| Q3 25 | — | $13.2M | ||
| Q2 25 | — | $13.8M | ||
| Q1 25 | — | $13.1M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | — | $10.9M | ||
| Q2 24 | $9.5M | $11.6M | ||
| Q1 24 | — | $10.7M |
净利润
CLLS
TACT
| Q4 25 | — | — | ||
| Q3 25 | — | $15.0K | ||
| Q2 25 | — | $-143.0K | ||
| Q1 25 | — | $19.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-551.0K | ||
| Q2 24 | $-25.3M | $-319.0K | ||
| Q1 24 | — | $-1.0M |
毛利率
CLLS
TACT
| Q4 25 | — | 47.6% | ||
| Q3 25 | — | 49.8% | ||
| Q2 25 | — | 48.2% | ||
| Q1 25 | — | 48.7% | ||
| Q4 24 | — | 44.2% | ||
| Q3 24 | — | 48.1% | ||
| Q2 24 | — | 52.7% | ||
| Q1 24 | — | 52.6% |
营业利润率
CLLS
TACT
| Q4 25 | — | -10.1% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | -1.9% | ||
| Q1 25 | — | -0.1% | ||
| Q4 24 | — | -10.3% | ||
| Q3 24 | — | -7.7% | ||
| Q2 24 | -181.1% | -3.8% | ||
| Q1 24 | — | -12.2% |
净利率
CLLS
TACT
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | -1.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | -265.9% | -2.8% | ||
| Q1 24 | — | -9.7% |
每股收益(稀释后)
CLLS
TACT
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | — | $-0.06 | ||
| Q2 24 | $-0.28 | $-0.03 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $149.0M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $148.6M | $31.1M |
| 总资产 | $407.1M | $44.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CLLS
TACT
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $20.0M | ||
| Q2 25 | — | $17.7M | ||
| Q1 25 | — | $14.2M | ||
| Q4 24 | — | $14.4M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | $149.0M | $11.1M | ||
| Q1 24 | — | $10.6M |
股东权益
CLLS
TACT
| Q4 25 | — | $31.1M | ||
| Q3 25 | — | $31.8M | ||
| Q2 25 | — | $31.3M | ||
| Q1 25 | — | $30.9M | ||
| Q4 24 | — | $30.6M | ||
| Q3 24 | — | $38.4M | ||
| Q2 24 | $148.6M | $38.5M | ||
| Q1 24 | — | $38.6M |
总资产
CLLS
TACT
| Q4 25 | — | $44.8M | ||
| Q3 25 | — | $45.0M | ||
| Q2 25 | — | $44.5M | ||
| Q1 25 | — | $44.2M | ||
| Q4 24 | — | $44.0M | ||
| Q3 24 | — | $50.5M | ||
| Q2 24 | $407.1M | $50.4M | ||
| Q1 24 | — | $51.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $28.9M | $609.0K |
| 自由现金流经营现金流 - 资本支出 | $27.6M | $589.0K |
| 自由现金流率自由现金流/营收 | 290.5% | 5.1% |
| 资本支出强度资本支出/营收 | 13.2% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $7.6M |
8季度趋势,按日历期对齐
经营现金流
CLLS
TACT
| Q4 25 | — | $609.0K | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-161.0K | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | $327.0K | ||
| Q2 24 | $28.9M | $636.0K | ||
| Q1 24 | — | $-1.5M |
自由现金流
CLLS
TACT
| Q4 25 | — | $589.0K | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-171.0K | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | $259.0K | ||
| Q2 24 | $27.6M | $499.0K | ||
| Q1 24 | — | $-1.6M |
自由现金流率
CLLS
TACT
| Q4 25 | — | 5.1% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | — | -1.3% | ||
| Q4 24 | — | 23.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | 290.5% | 4.3% | ||
| Q1 24 | — | -14.9% |
资本支出强度
CLLS
TACT
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | 13.2% | 1.2% | ||
| Q1 24 | — | 1.0% |
现金转化率
CLLS
TACT
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图